Global Pharmacovigilance Market Size, Share, and Growth & Trends Analysis Report by Service Provider (In-house, Contract Outsourcing) By Product Type (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining): Regional Outlook, Growth Potential and Segments Forecast 2024-2031

Loading...

Budget constraints? Get in touch with us for special pricing

Buying Options

Original price was: $6,000.00.Current price is: $5,100.00.
Original price was: $5,000.00.Current price is: $4,500.00.
Original price was: $4,000.00.Current price is: $3,800.00.
Loading...

Description

The Global Pharmacovigilance Market size was USD 7.5 billion in 2023 and is projected to reach USD 12.86 billion by 2031, with a CAGR of 7.1% during the forecast period.

Global Pharmacovigilance Market: Overview

The greater number of Adverse Drug Reactions (ADRs) resulting from drug abuse, in addition to the growing number of disorders that require combination treatment, constitute significant driver of the pharmacovigilance market. The United States FDA and EMA’s regulations ensure drug safety, bolstering the industry. Advances in ADR databases enhance reliability and make it easier study. The increased creation of personalised medications and biosimilars that are in addition to persistent illnesses such as cancer and Type 2 diabetes, drives up drugs utilisation and pharmacovigilance need. According to the World Health Organisation, nonhospital pharma consumption is driven by ongoing medical medications. Drug manufacturers are outsourcing pharmacovigilance services in order to save money, so Contract Research Organisations (CROs) as well Business Process Outsourcing (BPO) firms tend to be prominent competitors in this highly saturated marketplace, providing specialised services such as medical writing and information about clinical trials collection.

Global Pharmacovigilance Market: Covid-19 Impact

The COVID-19 pandemic underscored the vital function of pharmacovigilance for guaranteeing drug and vaccine safety. The swift growth of COVID-19 medicines and immunisations required operational pharmacovigilance systems to identify and react to adverse events. The worldwide epidemic has accelerated digital change in pharmacovigilance, leading to the application of AI and real-world evidence for improved tracking of safety. For instance, IQVIA utilised powered by artificial intelligence agents for handling inquiries from patients, and the WHO technical workshop offered methods to improve pharmacovigilance. These efforts highlight the significance of cutting-edge technology and strong structures for ensuring medicine as well as vaccine safety all through the pandemic.

Global Pharmacovigilance Market: Growth Drivers

  • Regulatory Mandates:

Stringent regulations for pharmacovigilance activities, such as adverse incidents reporting and plans for risk management, are driving the pharmaceutical sector ahead. Pharmaceutical companies are obligated by regulatory organisations around the world to monitor the efficacy of their drugs once they are released onto the market and report any side effects as soon as feasible.

  • Increasing Drug Complexity:

The expanding variety of medications, including biologics, biosimilars, and genetic treatments, has raised the need for pharmacovigilance services. These advanced drugs present distinct safety challenges, notably immunogenicity and long-term safety tracking, requesting thorough drug surveillance procedures.

  • Globalization of Clinical Trials:

The globalisation of research studies has expanded the geographical reach of pharmaceutical surveillance efforts. Pharmaceutical companies perform studies in a wide range of characteristics and regions, necessitating an effective pharmacovigilance network to ensure research participants’ safety and compliance with regulations across jurisdictions.

Global Pharmacovigilance Market: Restraining Factors

  • Data Management Challenges:

Managing and analysing enormous quantities of pharmacovigilance data poses substantial obstacles for drug manufacturers and regulatory agencies. Data integration, standardisation, & recognition of signals require complex technological infrastructures and skills, leading to resource restrictions and inefficiencies in operation.

  • Reporting Burden:

The adverse event reporting obligations place a significant burden on pharma businesses, notably when it comes of time, resources, or regulatory expenses. To ease the strain and improve efficiency, reporting procedures must be streamlined and automated using contemporary pharmacovigilance technologies.

Global Pharmacovigilance Market:  Opportunity Factors

  • Technological Advancements:

The use of AI, deep learning, and processing of natural languages are transforming pharmacovigilance procedures. These advanced analytics techniques enable improved detection of signals, risk assessment, and trend analysis, increasing the accuracy and timeliness of safety surveillance.

  • Real-world Evidence:

The increasing amount of real-world information and proof in pharmacovigilance creates customers for enhanced safety surveillance and risk control. Using electronic medical records (EHRs), social media tracking, and outcomes reported by patients might give helpful data about drug safety profile and patient outcomes in real-life situations.

Global Pharmacovigilance Market: Challenges

  • Regulatory Compliance:

Pharmacovigilance suppliers and pharmaceutical companies face a problem in keeping up with the growing legal criteria and standards. Compliance that has several laws and regulations across locations demands ongoing education, expertise, and expenditure on regulation information tools.

  • Resource Constraints:

Pharmacovigilance operations face issues due to limited personnel and finances, especially for medium-sized and small pharma businesses. Finding and keeping skilled pharmacovigilance experts, developing in IT infrastructure, and managing rising regulatory expenses require careful resource allocation and optimisation.

Global Pharmacovigilance Market: Segmentation

Based on Service Provider: The market is segmented into In-house pharmacovigilance and Contract Outsourcing. Contract outsourcing currently holds the largest market share.

Based on Product Type: The market is segmented into Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, and EHR Mining. Spontaneous Reporting is a major contributor to market revenue.

Global Pharmacovigilance Market: Regional Insights

  • North America:

North America is the largest market for pharmacovigilance services, owing to robust regulations, an elevated incidence of chronic illnesses, and an important pharmaceutical industry presence. The region advantages from an established pharmacovigilance facilities cutting-edge technology uptake, and rigorous oversight by regulators. North America had the greatest market share in 2023, mitigating around 41.2%, thanks to its abundance of medical equipment and significant pharmaceutical companies. The surge in illicit drug use and associated Adverse Drug Reactions (ADRs) is an important contributor of death and disability, as well as attributing to the region’s outstanding growth potential. Public attention is increasing, and substantial competitors have begun taking offensives to expand the business.

  • Asia Pacific:

The Asia Pacific pharmacovigilance business is experiencing rapid growth owing to growing pharmaceutical R&D, increasing expenditures on healthcare, and tighter oversight from regulators. Key countries like China, Japan, and India are fuelling this expansion. India’s pharmaceutical market is projected to reach $65 billion by 2024, making it an important market for contracted pharmacovigilance services. China’s stringent pharmaceutical security requirements, combined with a $160 billion market by 2023, promote demand for those services. Japan’s strong pharmacovigilance system its emphasis on sophisticated medicine expands the supply chain. The ASEAN area continues to grow due to increased R&D and healthcare spending. Contracting to qualified, inexpensive local Clinical research organisations and BPO businesses is a major trend.

Global Pharmacovigilance Market: Competitive Landscape

IQVIA Holdings Inc., PAREXEL International Corporation, ICON plc, Cognizant Technology Solutions Corporation, Accenture plc, IBM Corporation, Capgemini SE, and Oracle Corporation.

Global Pharmacovigilance Market: Recent Developments

  • IBM: On March 6, 2024, both IBM India and C-DAC have planned to progress India’s processor designing to manufacturing to improve its High Performance Computing.

Table of Content

CHAPTER 1: EXECUTIVE SUMMARY
1.1. Summary
CHAPTER 2: RESEARCH METHODOLOGY
2.1. Research Process
2.2. Primary Research
2.3. Secondary Research
2.4. Market Size Estimation
2.5. Research Methodology
2.6. Analyst Tools/Models/Techniques
2.6.1. Notations
2.7. Market Scope & Segmentation
2.8. Currency & Pricing Considered
CHAPTER 3: MARKET TRENDS
3.1. Introduction
3.2. Drivers
3.2.1. Regulatory Mandates
3.3. Restraints
3.3.1. Reporting Burden
3.4. Opportunities
3.4.1. Real-world Evidence
3.5. Challenges
3.5.1. Resource Constraints
3.6. Investment Feasibility Analysis
3.7. Latest Trends
CHAPTER 4: MARKET ASSESSMENT
4.1. Porters Five Forces Analysis
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitute
4.1.5. Intensity of Competitive Rivalry
4.2. Value Chain Analysis
4.3. Market Share Analysis
4.4. Impact of Key Regulations on the Market
4.5. SWOT Analysis
4.6. PESTEL Analysis
4.7. Patent Analysis
4.7.1. By SERVICE PROVIDER
4.7.2. By PRODUCT TYPE
4.8. Roadmap Development
4.9. Market Lineage Outlook
4.9.1. Parent Market Outlook
4.9.2. Ancillary Market Outlook
CHAPTER 5: IMPACT OF RECESSION ON THE MARKET
5.1. Introduction
5.1.1. Short Term Impact
5.1.2. Long Term Impact
CHAPTER 6: GLOBAL PHARMACOVIGILANCE MARKET, BY SERVICE PROVIDER
6.1. Introduction
6.1.1. Market Size & Forecast
6.1.2. Global PHARMACOVIGILANCE Market Share, by Service Provider -2023 and 2031 (%)
6.2. SERVICE IN-HOUSE PHARMACOVIGILANCE
6.2.1. Key market Trends, Growth Factors, and Opportunities
6.2.2. Market Size and Forecast, by Regions
6.3. SERVICE CONTRACT OUTSOURCING
6.3.1. Key market Trends, Growth Factors, and Opportunities
6.3.2. Market Size and Forecast, by Regions
CHAPTER 7: GLOBAL PHARMACOVIGILANCE MARKET, BY PRODUCT TYPE
7.1. Introduction
7.1.1. Market Size & Forecast
7.1.2. Global PHARMACOVIGILANCE Market Share, PRODUCT TYPE -2023 and 2031 (%)
7.2. SPONTANEOUS REPORTING
7.2.1. Key market Trends, Growth Factors, and Opportunities
7.2.2. Market Size and Forecast, by Regions
7.3. INTENSIFIED ADR REPORTING
7.3.1. Key market Trends, Growth Factors, and Opportunities
7.3.2. Market Size and Forecast, by Regions
7.4. TARGETED SPONTANEOUS REPORTING
7.4.1. Key market Trends, Growth Factors, and Opportunities
7.4.2. Market Size and Forecast, by Regions
7.5. COHORT EVENT MONITORING
7.5.1. Key market Trends, Growth Factors, and Opportunities
7.5.2. Market Size and Forecast, by Regions
7.6. EHR MINING
7.6.1. Key market Trends, Growth Factors, and Opportunities
7.6.2. Market Size and Forecast, by Regions
CHAPTER 8: NORTH AMERICA MARKET ANALYSIS
8.1. Introduction
8.2. PHARMACOVIGILANCE Market by Country
8.3. North America PHARMACOVIGILANCE Market by Country, USD Million 2019-2031
8.3.1. Market Size & Forecast, By SERVICE PROVIDER
8.3.2. Market Size & Forecast, by PRODUCT TYPE
8.4. U.S.
8.4.1. Market Size & Forecast, By SERVICE PROVIDER
8.4.2. Market Size & Forecast, by PRODUCT TYPE
8.5. Canada
8.5.1. Market Size & Forecast, By SERVICE PROVIDER
8.5.2. Market Size & Forecast, by PRODUCT TYPE
CHAPTER 9: EUROPE MARKET ANALYSIS
9.1. Introduction
9.2. PHARMACOVIGILANCE Market by Country
9.3. Europe PHARMACOVIGILANCE Market by Country, USD Million 2019-2031
9.3.1. Market Size & Forecast, By SERVICE PROVIDER
9.3.2. Market Size & Forecast, by PRODUCT TYPE
9.4. Germany
9.4.1. Market Size & Forecast, By SERVICE PROVIDER
9.4.2. Market Size & Forecast, by PRODUCT TYPE
9.5. France
9.5.1. Market Size & Forecast, By SERVICE PROVIDER
9.5.2. Market Size & Forecast, by PRODUCT TYPE
9.6. U.K.
9.6.1. Market Size & Forecast, By SERVICE PROVIDER
9.6.2. Market Size & Forecast, by PRODUCT TYPE
9.6.3. Market Size & Forecast, By SERVICE PROVIDER
9.6.4. Market Size & Forecast, by PRODUCT TYPE
9.7. Spain
9.7.1. Market Size & Forecast, By SERVICE PROVIDER
9.7.2. Market Size & Forecast, by PRODUCT TYPE
9.8. Benelux
9.8.1. Market Size & Forecast, By SERVICE PROVIDER
9.8.2. Market Size & Forecast, by PRODUCT TYPE
9.9. Rest of Europe
9.9.1. Market Size & Forecast, By SERVICE PROVIDER
9.9.2. Market Size & Forecast, by PRODUCT TYPE
CHAPTER 10: ASIA-PACIFIC MARKET ANALYSIS
10.1. Introduction
10.2. PHARMACOVIGILANCE Market by Country
10.3. Asia Pacific Cloud Storage Market by Country, USD Million 2019-2031
10.3.1. Market Size & Forecast, By SERVICE PROVIDER
10.3.2. Market Size & Forecast, by PRODUCT TYPE
10.4. China
10.4.1. Market Size & Forecast, By SERVICE PROVIDER
10.4.2. Market Size & Forecast, by PRODUCT TYPE
10.5. India
10.5.1. Market Size & Forecast, By SERVICE PROVIDER
10.5.2. Market Size & Forecast, by PRODUCT TYPE
10.6. Japan
10.6.1. Market Size & Forecast, By SERVICE PROVIDER
10.6.2. Market Size & Forecast, by PRODUCT TYPE
10.7. Australia
10.7.1. Market Size & Forecast, By SERVICE PROVIDER
10.7.2. Market Size & Forecast, by PRODUCT TYPE
10.8. South Korea
10.8.1. Market Size & Forecast, By SERVICE PROVIDER
10.8.2. Market Size & Forecast, by PRODUCT TYPE
10.9. Souethest Asia
10.9.1. Market Size & Forecast, By SERVICE PROVIDER
10.9.2. Market Size & Forecast, by PRODUCT TYPE
10.10. Rest of Asia Pacific
10.10.1. Market Size & Forecast, By SERVICE PROVIDER
10.10.2. Market Size & Forecast, by PRODUCT TYPE
CHAPTER 11: LATIN AMERICA AND THE CARIBBEAN MARKET ANALYSIS
11.1. Introduction
11.2. PHARMACOVIGILANCE Market by Country
11.3. Latin America PHARMACOVIGILANCE Market by Country, USD Million 2019-2031
11.3.1. Market Size & Forecast, By SERVICE PROVIDER
11.3.2. Market Size & Forecast, by PRODUCT TYPE
11.4. Brazil
11.4.1. Market Size & Forecast, By SERVICE PROVIDER
11.4.2. Market Size & Forecast, by PRODUCT TYPE
11.5. Mexico
11.5.1. Market Size & Forecast, By SERVICE PROVIDER
11.5.2. Market Size & Forecast, by PRODUCT TYPE
11.6. Rest of Latin America
11.6.1. Market Size & Forecast, By SERVICE PROVIDER
11.6.2. Market Size & Forecast, by PRODUCT TYPE
CHAPTER 12: THE MIDDLE EAST AND AFRICA MARKET ANALYSIS
12.1. Introduction
12.2. PHARMACOVIGILANCE Market by Country
12.3. MEA PHARMACOVIGILANCE Market by Country, USD Million 2019-2031
12.3.1. Market Size & Forecast, By SERVICE PROVIDER
12.3.2. Market Size & Forecast, by PRODUCT TYPE
12.4. South Africa
12.4.1. Market Size & Forecast, By SERVICE PROVIDER
12.4.2. Market Size & Forecast, by PRODUCT TYPE
12.5. Saudi Arabia
12.5.1. Market Size & Forecast, By SERVICE PROVIDER
12.5.2. Market Size & Forecast, by PRODUCT TYPE
12.6. UAE
12.6.1. Market Size & Forecast, By SERVICE PROVIDER
12.6.2. Market Size & Forecast, by PRODUCT TYPE
12.7. Rest of MEA
12.7.1. Market Size & Forecast, By SERVICE PROVIDER
12.7.2. Market Size & Forecast, by PRODUCT TYPE
CHAPTER 13: COMPETITIVE LANDSCAPE
13.1. Introduction
13.2. Market Player Positioning, 2022
13.3. Company Evaluation Matrix
13.4. Product Mapping of Top 10 Player
13.5. Market Opportunities and Future Trends
13.6. Competitive Heatmap
13.7. Top Winning Growth Strategies
13.7.1. Major Growth Strategies
13.7.2. Expansion
13.7.3. Merger and Acquisition
13.7.4. Other Developments
CHAPTER 14: COMPANY PROFILES
14.1. IQVIA HOLDINGS INC.
14.1.1. Company Overview
14.1.2. Key Executives
14.1.3. Financial Overview
14.1.4. Business Service Providernalysis
14.1.5. Product Portfolio
14.1.6. Key Strategic Developments
14.2. PAREXEL INTERNATIONAL CORPORATION
14.3. ICON PLC
14.4. COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION
14.5. ACCENTURE PLC
14.6. IBM CORPORATION
14.7. CAPGEMINI SE
14.8. ORACLE CORPORATION
14.9. Others

Tables & Figures

LIST OF TABLES
Table 1. Global PHARMACOVIGILANCE Market INDUSTRY SNAPSHOT, 2022-2031
Table 2. Global PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 3. Global PHARMACOVIGILANCE Market SERVICE IN-HOUSE PHARMACOVIGILANCE, BY REGION-2019-2031 (USD MILLION)
Table 4. Global PHARMACOVIGILANCE Market SERVICE CONTRACT OUTSOURCING, BY REGION-2019-2031 (USD MILLION)
Table 5. Global PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE SIZE-2019-2031 (USD MILLION)
Table 6. Global PHARMACOVIGILANCE Market SPONTANEOUS REPORTING, BY REGION-2019-2031 (USD MILLION)
Table 7. Global PHARMACOVIGILANCE Market INTENSIFIED ADR REPORTING, BY REGION-2019-2031 (USD MILLION)
Table 8. Global PHARMACOVIGILANCE Market TARGETED SPONTANEOUS REPORTING, BY REGION-2019-2031 (USD MILLION)
Table 9. Global PHARMACOVIGILANCE Market COHORT EVENT MONITORING, BY REGION-2019-2031 (USD MILLION)
Table 10. Global PHARMACOVIGILANCE Market EHR MINING, BY REGION-2019-2031 (USD MILLION)
Table 11. NORTH AMERICA PHARMACOVIGILANCE Market BY COUNTRY, USD MILLION 2019-2031
Table 12. NORTH AMERICA PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 13. NORTH AMERICA PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 14. U.S. PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 15. U.S. PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 16. CANADA PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 17. CANADA PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 18. EUROPE PHARMACOVIGILANCE Market BY COUNTRY, USD MILLION 2019-2031
Table 19. EUROPE PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 20. EUROPE PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 21. GERMANY PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 22. GERMANY PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 23. FRANCE PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 24. FRANCE PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 25. UK PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 26. UK PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 27. ITALY PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 28. ITALY PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 29. SPAIN PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 30. SPAIN PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 31. BENELUX PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 32. BENELUX PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 33. REST OF EUROPE PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 34. REST OF EUROPE PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 35. ASIA PACIFIC PHARMACOVIGILANCE Market BY COUNTRY, USD MILLION 2019-2031
Table 36. ASIA PACIFIC PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 37. ASIA PACIFIC PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 38. CHINA PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 39. CHINA PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 40. INDIA PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 41. INDIA PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 42. JAPAN PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 43. JAPAN PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 44. AUSTRALIA PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 45. AUSTRALIA PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 46. SOUTH KOREA PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 47. SOUTH KOREA PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 48. SOUETHEST ASIA PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 49. SOUETHEST ASIA PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 50. REST OF ASIA PACIFIC PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 51. REST OF ASIA PACIFIC PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 52. LATIN AMERICA PHARMACOVIGILANCE Market BY COUNTRY, USD MILLION 2019-2031
Table 53. LATIN AMERICA PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 54. LATIN AMERICA PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 55. BRAZIL PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 56. BRAZIL PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 57. MEXICO PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 58. MEXICO PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 59. REST OF LATIN AMERICA PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 60. REST OF LATIN AMERICA PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 61. MEA PHARMACOVIGILANCE Market BY COUNTRY, USD MILLION 2019-2031
Table 62. MEA PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 63. MEA PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 64. SOUTH AFRICA PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 65. SOUTH AFRICA PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 66. SAUDI ARABIA PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 67. SAUDI ARABIA PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 68. UAE PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 69. UAE PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 70. REST OF MEA PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2019-2031 (USD MILLION)
Table 71. REST OF MEA PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2019-2031 (USD MILLION)
Table 72. KEY EXPANSIONS (2019-2022)
Table 73. KEY MERGERS AND ACQUISITION (2019-2022)
Table 74. OTHER KEY DEVELOPMENTS (2019-2022)

LIST OF FIGURES
Figure 1. REGIONAL ANALYSIS (2022 & 2031)
Figure 2. RESEARCH PROCESS
Figure 3. ANALYSIS FRAMEWORK
Figure 4. IMPACT OF KEY REGULATION ON THE MARKET
Figure 5. SWOT ANALYSIS
Figure 6. Global PHARMACOVIGILANCE Market SHARE, by SERVICE PROVIDER -2023 & 2031 (USD MILLION)
Figure 7. Global PHARMACOVIGILANCE Market , SERVICE IN-HOUSE PHARMACOVIGILANCE -2019-2031 (USD MILLION)
Figure 8. Global PHARMACOVIGILANCE Market , SERVICE CONTRACT OUTSOURCING -2019-2031 (USD MILLION)
Figure 9. Global PHARMACOVIGILANCE Market , SERVICE PROVIDER.3 -2019-2031 (USD MILLION)
Figure 10. Global PHARMACOVIGILANCE Market , SERVICE PROVIDER.4 -2019-2031 (USD MILLION)
Figure 11. Global PHARMACOVIGILANCE Market , SERVICE PROVIDER.5 -2019-2031 (USD MILLION)
Figure 12. Global PHARMACOVIGILANCE Market SHARE, by PRODUCT TYPE -2023 & 2031 (USD MILLION)
Figure 13. Global PHARMACOVIGILANCE Market , SPONTANEOUS REPORTING -2019-2031 (USD MILLION)
Figure 14. Global PHARMACOVIGILANCE Market , INTENSIFIED ADR REPORTING -2019-2031 (USD MILLION)
Figure 15. Global PHARMACOVIGILANCE Market , TARGETED SPONTANEOUS REPORTING -2019-2031 (USD MILLION)
Figure 16. Global PHARMACOVIGILANCE Market , COHORT EVENT MONITORING -2019-2031 (USD MILLION)
Figure 17. Global PHARMACOVIGILANCE Market , EHR MINING -2019-2031 (USD MILLION)
Figure 18. Global PHARMACOVIGILANCE Market SHARE, by SEGMENT C -2023 & 2031 (USD MILLION)
Figure 19. Global PHARMACOVIGILANCE Market , SEGMENT C.1 -2019-2031 (USD MILLION)
Figure 20. Global PHARMACOVIGILANCE Market , SEGMENT C.2 -2019-2031 (USD MILLION)
Figure 21. Global PHARMACOVIGILANCE Market , SEGMENT C.3 -2019-2031 (USD MILLION)
Figure 22. Global PHARMACOVIGILANCE Market , SEGMENT C.4 -2019-2031 (USD MILLION)
Figure 23. Global PHARMACOVIGILANCE Market , SEGMENT C.5 -2019-2031 (USD MILLION)
Figure 24. Global PHARMACOVIGILANCE Market SHARE, by SEGMENT D -2023 & 2031 (USD MILLION)
Figure 25. Global PHARMACOVIGILANCE Market , SEGMENT D.1 -2019-2031 (USD MILLION)
Figure 26. Global PHARMACOVIGILANCE Market , SEGMENT D.2 -2019-2031 (USD MILLION)
Figure 27. Global PHARMACOVIGILANCE Market , SEGMENT D.3 -2019-2031 (USD MILLION)
Figure 28. Global PHARMACOVIGILANCE Market , SEGMENT D.4 -2019-2031 (USD MILLION)
Figure 29. Global PHARMACOVIGILANCE Market , SEGMENT D.5 -2019-2031 (USD MILLION)
Figure 30. MARKET PLAYER POSITIONING, 2022
Figure 31. COMPANY EVALUATION MATRIX
Figure 32. PRODUCT MAPPING OF TOP 10 PLAYERS
Figure 33. COMPETITIVE HEATMAP OF KEY PLAYERS

Frequently Asked Questions (FAQ):

  • What is the current size of the Global Pharmacovigilance Market?

    The Global Pharmacovigilance Market size was USD 7.5 billion in 2023 and is projected to reach USD 12.86 billion by 2031, with a CAGR of 7.1% during the forecast period.
  • Which is the leading segment in the Global Pharmacovigilance Market?

    Based on Service Provider, Contract outsourcing currently holds the largest market share.
  • What are the key factors driving the Global Pharmacovigilance Market?

    The growing prevalence of ADRs, advancements in drug development, growing awareness of patient safety are the major factors driving the market growth.
  • Which region will contribute notably towards the Global Pharmacovigilance Market?

    North America region to contribute the major share towards the market growth.

Buying Options

Original price was: $6,000.00.Current price is: $5,100.00.
Original price was: $5,000.00.Current price is: $4,500.00.
Original price was: $4,000.00.Current price is: $3,800.00.